Skip to main content

Table 2 Newcastle-Ottawa scale score of the reviewed studies

From: Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis

Study

Selection (4 stars)

Comparability (2 stars)

Outcome (3 stars)

Total score

Representativeness of the hypertensive cohort

Selection of the non-hypertensive cohort

Ascertainment of hypertension

Demonstration that outcome of interest was not present at start of study

Assessment of outcome

Was follow up long enough for outcomes to occur?

Adequacy of follow up of cohort

Rini (a)

7

Szmit

9

Bono

7

Fujita

7

Eechoute

7

Rini (b)

7

Motzer

6

Hong

7

Nakano

7

Fujita

7

Eto

7

Rini (c)

7

Zhang (a)

7

Kucharz

7

Izzedine

8

Donskov

7

Zhang (b)

7

Goldstein

9

Miyake

7

Fukuda

7

Matias

7

  1. —: The data were not available in this study